Kesler Norman & Wride’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44M Buy
33,980
+2,127
+7% +$200K 0.39% 69
2026
Q1
$3.77M Buy
31,853
+2,240
+8% +$277K 0.65% 52
2025
Q4
$3.73M Buy
29,613
+24,759
+510% +$3.23M 0.64% 53
2025
Q3
$791K Sell
4,854
-21,988
-82% -$3.32M 0.16% 129
2025
Q2
$4.19M Buy
26,842
+21,312
+385% +$3.38M 0.74% 48
2025
Q1
$912K Buy
5,530
+676
+14% +$112K 0.17% 116
2024
Q4
$791K Sell
4,854
-403
-8% -$72.1K 0.17% 124
2024
Q3
$1.03M Sell
5,257
-1,054
-17% -$194K 0.2% 99
2024
Q2
$1.09M Sell
6,311
-5
-0.1% -$832 0.23% 98
2024
Q1
$1.07M Buy
6,316
+284
+5% +$53.2K 0.23% 102
2023
Q4
$1.19M Buy
6,032
+728
+14% +$129K 0.27% 94
2023
Q3
$923K Buy
5,304
+1,637
+45% +$297K 0.23% 108
2023
Q2
$632K Buy
3,667
+1,004
+38% +$174K 0.15% 122
2023
Q1
$443K Buy
+2,663
New +$436K 0.11% 131

Other funds holding ZTS

Kesler Norman & Wride's ZTS Position: Q2 2026 in Review

Kesler Norman & Wride increased its Zoetis (ZTS) stake by 6.7% in Q2 2026, buying an estimated $200K and bringing the position to 33,980 shares worth $2.44M. The position accounts for 0.39% of the portfolio, ranked #69.

Kesler Norman & Wride first reported a position in ZTS in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.19M in Q2 2025. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Kesler Norman & Wride held 33,980 shares of Zoetis worth $2.44M as of Q2 2026.
  • Kesler Norman & Wride bought 2,127 Zoetis shares in Q2 2026, an estimated $200K.
  • Zoetis made up 0.39% of Kesler Norman & Wride's portfolio in Q2 2026, its #69 holding.
  • Kesler Norman & Wride first reported a position in Zoetis in Q1 2023 and has held it in 14 quarters since.
  • Kesler Norman & Wride's Zoetis position peaked at $4.19M in Q2 2025.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.